Our analysis identified a CRLM-specific signature that clearly discriminated metastatic samples from normal liver tissue and revealed a high degree of tumor heterogeneity in the genes of the EGFR and the WNT pathways, which have previously been associated with poor survival in CRC. The gene discussed is EGFR; the disease is neoplasm.